Yearly New Drug Approvals: Gifts of Innovation in Oncology

This chapter presents an engaging review of the 2024 drug approvals, likening them to holiday gifts categorized as 'keep', 're-gift', or 'return'. The host highlights innovative cancer therapies while exploring their potential applications and implications in the pharmaceutical landscape.